Accessibility and Me

January 22, 2021
By Joe Banks, 23andMe Tech Lead Editor’s note: This post by 23andMe’s Joe Banks, first appeared on 23andMe’s engineering blog. We’re reprinting an excerpt of it here to highlight issues...
Read More

23andMe Awarded LEED Platinum Status for HQ’s Environmental Design  

January 06, 2021
Like most offices in Silicon Valley, these days 23andMe’s headquarters is largely vacant as employees have adjusted to working from home during the pandemic. But that hasn’t stopped us all...
Read More

23andMe Receives Data Security and Privacy Certifications

October 29, 2020
23andMe recently received two additional privacy certifications from third-party auditors, while successfully re-certifying an existing security certification.  ISO certifications are awarded after extensive audits by independent third-parties. An international standard-setting...
Read More

New Study on People’s Response to Information from Direct-to-Consumer Genetic Testing

October 08, 2020
Studying the impact of direct-to-consumer genetic testing on consumers, 23andMe scientists found that people who received information about genetic risk for a certain type of blood clots, found it useful, and in some cases, took actions to lower their risk.
Read More

23andMe+: An ongoing approach to your genetics

October 01, 2020
Starting today, we are offering current 23andMe health service customers in the U.S. access to 23andMe+, a new annual membership. This membership provides customers with exclusive access to genetic reports,...
Read More

23andMe’s Commitment to Diversity, Equity & Inclusion

September 30, 2020
Last June, following the tragic deaths of George Floyd and so many others in the Black community, our CEO pledged to hold ourselves accountable to make improvements to ensure our...
Read More

Making Good of Your Time

September 02, 2020
Jamie's experience volunteering at Camp Champ helped to lead 23andMe to add a new Volunteer Time Off benefit for all its employees.
Read More

FDA grants 23andMe clearance to offer interpretive drug information for two medications

August 18, 2020
The FDA granted 23andMe clearance to offer a pharmacogentics report on two commonly prescribed medications, one prescribed for heart conditions, and the other for depression.
Read More

23andMe and GSK Begin First Clinical Trial with Cancer Therapy

July 29, 2020
A drug to fight cancer will be the first potential therapy to emerge from 23andMe and GlaxoSmithKline collaboration as the two companies announced that the new therapy will begin clinical trials.
Read More

Introducing L. Okey Onyejekwe Jr.

July 27, 2020
We sit down for a chat with L. Okey Onyejekwe Jr., 23andMe's new vice president of Consumer Clinical Operations & Medical Affairs.
Read More